From January 1, 2024 to March 31, 2024, the company has repurchased 140,600 shares, representing 0.87% for ¥78.57 million. With this, the company has completed the repurchase of 228,700 shares, representing 1.41% for ¥125.36 million under the buyback announced on November 21, 2023.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
608 JPY | -5.74% | -4.70% | +16.70% |
04-09 | Tranche Update on IMV Corporation's Equity Buyback Plan announced on November 21, 2023. | CI |
03-25 | BioVaxys Technology Plans Private Placement; Down 5.9% | MT |
1st Jan change | Capi. | |
---|---|---|
+16.70% | 62.88M | |
+11.31% | 34.72B | |
+26.86% | 8.75B | |
+11.21% | 7.98B | |
+27.21% | 5.77B | |
+41.80% | 4.22B | |
-4.38% | 4.13B | |
+14.17% | 3.72B | |
+12.77% | 3.67B | |
-10.28% | 2.71B |
- Stock Market
- Equities
- 7760 Stock
- News IMV Corporation
- Tranche Update on IMV Corporation's Equity Buyback Plan announced on November 21, 2023.